Related Experiment Video
Updated: Feb 26, 2026

Author Spotlight: Developing a Safer and More Efficient Treatment Protocol for Wasting Marmoset Syndrome (WMS)
Published on: July 12, 2024
Update MRONJ and perspectives of its treatment
P J Voss1, P Poxleitner1, R Schmelzeisen1
1Department of oral and craniomaxillofacial surgery, center for dental medicine, university medical center Freiburg, Hugstetter Straße 55, 79106 Freiburg, Germany.
Abstract:
Antiresorptive agents are widely used in catabolic bone diseases. Not only bisphosphonates but also new drugs like Denosumab may induce osteonecrosis of the jaw as a side effect. The present review describes the current effect mechanisms of commonly used antiresorptives, pathogenetic theories for the development of antiresorptive-related osteonecrosis of the jaw (ARONJ), and potential risk factors. Furthermore, diagnostic modalities and treatment options as well as new and innovative strategies are discussed. The major key factor to avoid the occurrence of ARONJ still remains the implementation of throughout preventive measures.
Related Concept Videos
Treatment Resistant Cancers
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Rheumatic Heart Disease III: Medical Management
Pharmaceutical Poisoning: Treatment Strategies
Mitral Stenosis III: Medical Management
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...

